Stock Events

Stock Events

Sonoma Pharmaceuticals 

0
44
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q2 2026
Next
-0.26
-0.17
-0.08
0.01
Expected EPS
-0.08602
Actual EPS
N/A

Financials

-16.22%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
16.69MRevenue
-2.71MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow O8Z3.MU. It's not an investment recommendation.
NVIDIA
9
NVDA
Microsoft
8
MSFT
Amazon
8
AMZN
AMD
8
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson offers a wide range of healthcare products that compete with Sonoma Pharmaceuticals' dermatological and wound care products.
Pfizer
PFE
Mkt Cap159.36B
Pfizer develops and markets drugs and vaccines, including those for infections and inflammations, competing with Sonoma's infection prevention products.
Merck
MRK
Mkt Cap366B
Merck produces pharmaceuticals that directly compete with Sonoma Pharmaceuticals in the areas of infection and wound care.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie has a strong portfolio in dermatology, directly competing with Sonoma Pharmaceuticals' skin health products.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline has a diverse range of healthcare products, including those for skin health and infection control, making it a competitor.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb offers various healthcare products that compete in the therapeutic areas covered by Sonoma Pharmaceuticals.
Novartis
NVS
Mkt Cap292.35B
Novartis provides innovative healthcare solutions, including dermatology and wound care products, competing with Sonoma Pharmaceuticals.
AMGEN
AMGN
Mkt Cap233.78B
Amgen focuses on human therapeutics, including treatments for skin conditions and infections, competing with Sonoma's product range.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals specializes in biopharmaceuticals, competing in the dermatology and infection prevention market.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries offers generic and specialty medicines, including dermatological products, competing with Sonoma Pharmaceuticals.

About

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
Show more...
CEO
Amy Trombly
Employees
260
Country
United States
ISIN
US83558L2043

Listings

MU
DE
O8Z.MU
STU
DE
O8Z.STU
MU
DE
O8Z3.MU
XNAS
US
SNOA

0 Comments

Share your thoughts

FAQ

What is Sonoma Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Sonoma Pharmaceuticals stocks are traded under the ticker O8Z3.MU.
When is the next Sonoma Pharmaceuticals earnings date?▼
Sonoma Pharmaceuticals is going to release the next earnings report on November 16, 2026.
What were Sonoma Pharmaceuticals earnings last quarter?▼
O8Z3.MU earnings for the last quarter are 0.01 EUR per share, whereas the estimation was -0.26 EUR resulting in a +105.01% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Sonoma Pharmaceuticals revenue for the last year?▼
Sonoma Pharmaceuticals revenue for the last year amounts to 16.69M EUR.
What is Sonoma Pharmaceuticals net income for the last year?▼
O8Z3.MU net income for the last year is -2.71M EUR.
How many employees does Sonoma Pharmaceuticals have?▼
As of September 04, 2026, the company has 260 employees.
In which sector is Sonoma Pharmaceuticals located?▼
Sonoma Pharmaceuticals operates in the Health & Wellness sector.
When did Sonoma Pharmaceuticals complete a stock split?▼
The last stock split for Sonoma Pharmaceuticals was on August 30, 2024 with a ratio of 1:20.
Where is Sonoma Pharmaceuticals headquartered?▼
Sonoma Pharmaceuticals is headquartered in BOULDER, United States.